Iron deficiency and overload. Implications in oxidative stress and cardiovascular health;Deficiencia y sobrecarga de hierro; implicaciones en el estado oxidativo y la salud cardiovascular

Nutricion Hospitalaria

Volumn 25, Issue 3, 2010, Pages 350-365

  Toxqui, L ^a   De Piero, A ^b   Courtois, V ^b   Bastida, S ^b   Sanchez Muniz F J ^b   Vaquero, M P ^a  

^a INSTITUTE OF FOOD SCIENCE   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cardiovascular disease; Iron deficiency anemia; Iron metabolism; Iron overload; Nutrigenomics

Indexed keywords

IRON;

BIOAVAILABILITY; CARDIOVASCULAR DISEASE; HUMAN; INTESTINE ABSORPTION; IRON METABOLISM DISORDER; IRON OVERLOAD; METABOLISM; OXIDATIVE STRESS; REVIEW; RISK FACTOR;

BIOLOGICAL AVAILABILITY; CARDIOVASCULAR DISEASES; HUMANS; INTESTINAL ABSORPTION; IRON; IRON METABOLISM DISORDERS; IRON OVERLOAD; OXIDATIVE STRESS; RISK FACTORS;

EID: 77951956996     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.3.4583     Document Type: Review

References (118)

1. Conrad M, Umbreit J. Pathways of iron absorption. Blood Cells Mol Dis 2002; 29: 336-55.
2. Nadadur SS, Srirama K, Mudipalli A. Iron transport & home-ostasis mechanisms: their role in health & disease. Indian J Med Res 2008; 128: 533-44.
3. Conrad M, Umbreit J. Iron Absorption and Transport - An Update. Am J Hematol 2000; 64: 287-98. (Pubitemid 30622237)
4. West AR, Oates PS. Mechanisms of heme iron absorption: current questions and controversies. World J Gastroenterol 2008; 14: 4101-10.
5. Suárez, Heberto; Cimino, Franco; Bonilla, Ernesto. Hierro en el sistema nervioso central: metabolismo y consideraciones fisio- patológicas. Invest Clín 1985; 26: 247-322.
6. a edición: Saunders, 2006.
7. Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 2007; 68: 1820-5. (Pubitemid 46791395)
8. Koziorowski D, Friedman A, Arosio P, Santambrogio P, Dziewulska D. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control. Parkinsonism Relat Disord 2007; 13: 214-8. (Pubitemid 46603035)
9. Friedman A, Galazka-Friedman J, Bauminger ER, Koziorowski D. Iron and ferritin in hippocampal cortex and substantia nigra in human brain - implications for the possible role of iron in dementia. J Neurol Sci 2006; 248: 31-4. (Pubitemid 44647315)
10. Fiel MI, Schiano T. A woman with chronic anemia and cholestatic liver disease. Hepatology 2009; 49: 1390-1.
11. Pikuleva IA. Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos. 2006; 34: 513-20.
12. a Edición. Omega, 2001.
13. Viguria Padilla F, Miján de la Torre A. La pica: retrato de una entidad clínica poco conocida. Nutr Hosp 2006; 21: 557-66. (Pubitemid 44668736)
14. Sharp P, Srai SK. Molecular mechanisms involved in intestinal iron absorption. World J Gastroenterol 2007; 13: 4716-24. (Pubitemid 47455562)
15. Darshan D, Anderson GJ. Liver-gut axis in the regulation of iron homeostasis. World J Gastroenterol 2007; 13: 4737-45. (Pubitemid 47455564)
16. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005; 202: 199-211. (Pubitemid 40040559)
17. Lönnerdal B. Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care 2009; 12: 293-7.
18. Vidal Miñana MC, Farré Rovira R. Evaluación antropométrica del estado nutricional y estimación de las ingestas de hierro y de vitamina C de mujeres posmenopáusicas y hombres mayores de 45 años. Nutr Hosp 2001; 15: 162-9. (Pubitemid 33051691)
19. Tako E, Glahn RP, Welch RM, Lei X, Yasuda K, Miller DD. Dietary inulin affects the expression of intestinal enterocyte iron transporters, receptors and storage protein and alters the microbiota in the pig intestine. Br J Nutr 2008; 99: 472-80. (Pubitemid 351223414)
20. Patterson JK, Rutzke MA, Fubini SL, Glahn RP, Welch RM, Lei X, Miller DD. Dietary inulin supplementation does not promote colonic iron absorption in a porcine model. J Agric Food Chem 2009; 57: 5250-6.
21. Johnston KL, Johnson DM, Marks J, Srai SK, Debnam ES, Sharp PA. Non-haem iron transport in the rat proximal colon. Eur J Clin Invest 2006; 36: 35-40.
22. Van Dokkum. The concept of mineral bioavailability. En: Bioavailability of minerals and minor dietary components. Metabolic and technological aspects (MP Vaquero, T García-Arias, A Carbajal, FJ Sánchez-Muniz, eds), Research Signpost, Trivadrum, pp. 1-18, 2003.
23. Pérez-Granados AM, Navarro MP, Vaquero MP (2003). The frying process. Influence on the bioavailability of dietary minerals. En: Bioavailability of minerals and minor dietary components. Metabolic and technological aspects (MP Vaquero, T García-Arias, A Carbajal, FJ Sánchez-Muniz, eds), Research Signpost, Trivadrum, pp. 95-104.
24. Vaquero MP. Factores que intervienen en la biodisponibilidad mineral. Prevención de deficiencias. Revista de Nutrición Práctica 1998; 2: 15-23.
25. Hurrell RF, Reddy MB, Juillerat M, Cook JD. Meat protein fractions enhance nonheme iron absorption in humans. J Nutr 2006; 136: 2808-12. (Pubitemid 44771778)
26. Huh EC, Hotchkiss A, Brouillette J, Glahn RP. Carbohydrate fractions from cooked fish promote iron uptake by Caco-2 cells. J Nutr 2004; 134: 1681-9. (Pubitemid 38886555)
27. Armah CN, Sharp P, Mellon FA, Pariagh S, Lund EK, Dainty JR, Teucher B, Fairweather-Tait SJ. L-alpha-glycerophospho-choline contributes to meat's enhancement of nonheme iron absorption. J Nutr 2008; 138: 873-77. (Pubitemid 351571585)
28. Fernández R, Phillips SF. Components of fiber impair iron absorption in the dog. Am J Clin Nut 1989; 35: 107.
29. Vaquero MP, Pérez-Olleros L, García-Cuevas M, Veldhuizen. Ruíz-Roso B, Requejo A. Absorción de minerales de dietas que contienen fibra natural de algarrobas comparada con celulosa, pectina y varias combinaciones de estas fibras. Foof Sci Tech Int. 2000; 6: 463-71.
30. Bocanegra A, Nieto A, Blas B, Sánchez-Muniz FJ. Diets containing high percentage of Nori or Konbu algae are well accepted and efficiently used by growing rats but induce different degrees of histological changes in the liver and bowel. Food Chem. Toxicol 2003; 41: 1473-80. (Pubitemid 37088102)
31. Bocanegra A, Bastida S, Ródenas S, Benedí J, Sánchez-Muniz FJ. Characterisitics and nutricional and cardiovascular-heath properties of seaweeds. J Med Food 2009; 12: 236-58.
32. Bocanegra A, Nieto A, Bastida S, Benedí J, Sánchez-Muniz FJ. A Nori, but not a Konbu, dietary supplement decreases the cholesterolaemia, liver fat infiltration and mineral bioavailability in hypercholesterolemic growing Wistar rats. Br J Nutr 2008; 99: 272-80.
33. Lynch SR. Iron. In: Sadler MJ, Strain JJ, Caballero B, eds. Encyclopedia of Human Nutrition, Academic Press, vol. 2, pp. 1153-9, Londres, 1998.
34. Ganz T. Molecular control of iron transport. J Am Soc Nephrol 2007; 18: 394-400. (Pubitemid 46193304)
35. Mckie AT. The role of Dcytb in iron metabolism: an update. Biochem Soc Trans 2008; 36: 1239-41.
36. Piperno A, Mariani R, Trombini P, Girelli D. Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol 2009; 15: 538-51.
37. Weinstein D, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropiate expresion of hepcidin is associated with iron refractory anemia: implication for the anemia chronic disease. Blood 2002; 100: 3776-81. (Pubitemid 35303951)
38. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald MLE, Franchini PL, Dubé MP y cols. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004; 36: 77-82. (Pubitemid 38056211)
39. De Domenico I, Nemeth E, Nelson JM, Phillips JD, Ajioka RS, Kay MS, Kushner JP, Ganz T, Ward DM, Kaplan J. The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab 2008; 8: 146-56.
40. Vaiopoulos G, Papanikolaou G, Politou M, Jibreel I, Sakellaropoulos N, Loukopoulos D. Arthropathy in juvenile hemochromatosis. Arthritis Rheum 2003; 48: 227-30. (Pubitemid 36091667)
41. Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology Am Soc Hematol Educ Program 2003; 40-61.
42. Online Mendelian Inheritance in Man Database (OMIMD). En línea [http://www.ncbi.nlm.nih.gov/omim/] 20 de mayo de 2009.
43. Wolff F, Carreño N, Armas M, Caravallo A. Hemocromatosis Hereditaria. Complicaciones Reumatológicas. Reumatología 2004; 20: 139-48.
44. Arroyo E, Vaquero MP. Detección de mutaciones y su implicación en estados patológicos del metabolismo del hierro. En: Vaquero MP, ed. Genética, nutrición y enfermedad. Consejo Superior de Investigaciones Científicas, Instituto Tomás Pascual Sanz, Edimsa, pp. 147-156, Madrid, 2008.
45. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M y cols. The gen TfR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000; 25: 14-15. (Pubitemid 30257027)
46. Feder JN, Gnirke A, Thomas W y cols. A novel MHC class I-like gene is mutated in patiens with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408. (Pubitemid 26256612)
47. Merryweather-Clarke AT, Pointon M, Jouanolle AM y cols. Geography of HFE C282Y and H63 mutations. Genet Test 2000; 4: 183-98.
48. Beutler L, Beutler E. Hematogically important mutations: iron storage diseases. Blood Cells Mol Dis 2004; 33: 40-44. (Pubitemid 38829596)
49. Delatycki MB, Allen KJ, Gow P, MacFarlane J, Radomski C, Thompson J, Hayden MR, Goldberg YP, Samuels ME. A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis. Clin Genet 2004; 65: 378-83. (Pubitemid 38659706)
50. Lanzara C, Roetto A, Daraio F, Rivard S, Ficarella R, Simard H, Cox TM, Cazzola M, Piperno A, Gimenez-Roqueplo AP, Grammatico P, Volinia S, Gasparini P, Camaschella C. Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 2004; 103: 4317-21. (Pubitemid 38685379)
51. Lee PL, Beutler E, Rao SV, Barton JC. Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood 2004; 103: 4669-71. (Pubitemid 38746001)
52. Majore S, Binni F, Pennese A, De Santis A, Crisi A, Grammatico P. HAMP gene mutation c.208T > C (p.C70R) identified in an Italian patient with severe hereditary hemochromatosis. Hum Mutat 2004; 23 (4): 400.
53. Aleo Luján E, Gil López C, González Fernández FA, Villegas Martínez A, Valverde Moreno F. Receptor sérico de transferrina en niños sanos. Valor diagnóstico en la anemia infecciosa y en la ferropénica. An Pediatr (Barc) 2004; 60: 428-35.
54. Trinder D, Baker E. Tranferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 2003; 35: 292-6. (Pubitemid 36084450)
55. Hofmann WK, Tong XJ, Ajioka RS, Kushner JP, Koeffler HP. Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis. Blood 2002; 100: 1099-100.
56. Mattman A, Huntsman D, Lockith G y cols. Tranferrin receptor 2 (TFR2) and HFE mutational analysis non C-282Y iron overload. identification of a novel mutation. Blood 2002; 100: 1075-7. (Pubitemid 34832643)
57. Piperno A, Roetto A, Mariani R, Pelucchi S, Corengia C, Daraio F, Piga A, Garozzo G, Camaschella C. Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload. Haematologica 2004; 89: 359-60. (Pubitemid 38788423)
58. Lee PL, Halloran C, West C, Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol Dis 2001; 27: 285-9. (Pubitemid 32299783)
59. Organización Mundial de la Salud (OMS). En línea [http://www.who.int/es/] 20 de mayo de 2009.
60. De Paz R, Hernández-Navarro R. Manejo, prevención y control de síndrome anémico secundario a deficiencia férrica. Nutr Hosp 2005; 20: 364-7.
61. Muñoz M, Romero A, Morales M, Campos A, García-Erce JA, Ramírez G. Iron metabolism, inflammation and anemia in critically ill patients. A cross-sectional study. Nutr Hosp 2005; 20: 115-20. (Pubitemid 41787502)
62. Connor JR, Menzies SL. Relationship of iron to oligodendrocytes and myelination. Glia 1996; 17: 83-93.
63. Sarriá B, López-Parra AM, Navas-Carretero S, Pérez-Granados AM, Baeza C, Arroyo-Pardo E, Vaquero MP. Hepcidin, Transferrin (exon 7) and Hemochromatosis genotyping suggests that haplotype block analysis is the best strategy for predicting iron deficiency phenotype in women. Nutr Res 2007; 27: 672-8. (Pubitemid 350086766)
64. Navas-Carretero S, Baeza C, López-Parra AM, Tirado M, Arroyo-Pardo E, Vaquero MP. Ingesta de nutrientes y presencia de mutaciones en genes implicados en la deficiencia de hierro en un grupo de mujeres trabajadoras de la Comunidad de Madrid". Nutr Hosp 2008; 1: 144-5.
65. Sarriá B, Navas-Carretero S, Lopez-Parra AM, Perez-Granados AM, Arroyo-Pardo E, Roe MA, Teucher B, Fairweather-Tait SJ, Vaquero MP. The G277S transferrin mutation does not affect iron absorption in iron deficient women. Eur J Nutr 2007; 46: 57-60. (Pubitemid 46208262)
66. Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, López-Otín C. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 2009; 94: 840-9.
67. Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res 2003; 531: 81-92. (Pubitemid 37456724)
68. Brewer GJ. Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease. Exp Biol Med (Maywood) 2007; 232: 323-35.
69. Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 2003; 111: 163-9.
70. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
71. Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP, Huang D, Bordelon Y, Mintz J, Perlman S. Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res 2007; 32: 1655-64. (Pubitemid 47428858)
72. Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 2002; 91: 9-18. (Pubitemid 34727756)
73. Edison ES, Bajel A, Chandy M. Iron homeostasis: new players, newer insights. Eur J Haematol 2008; 81: 411-24.
74. Meyers DG. The iron hypothesis: does iron play a role in atherosclerosis? Transfusion 2000; 40: 1023-9.
75. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981; 1: 1293-4.
76. Sullivan JL. Macrophage iron, hepcidin, and atherosclerotic plaque stability. Exp Biol Med (Maywood) 2007; 232: 1014-20.
77. Sullivan JL. Iron in arterial plaque: A modifiable risk factor for atherosclerosis. Biochim Biophys Acta 2009; 1790: 718-23.
78. Fanchini M, Targher G, Montagnana M, Lippi G., Iron and thrombosis. Ann Hematol 2008; 87: 167-173.
79. Salonen JT, Nyyssonen K, Korpela H, Toumiletto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 1992; 86: 803-811. (Pubitemid 23165654)
80. Lauffer Rb. Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses 1991; 35: 96-102.
81. Sullivan JL. Heterozygous hemochromatosis as a risk factor for premature myocardial infarction. Med Hypotheses 1990; 31: 1-5. (Pubitemid 20042686)
82. Kiechl S, Aichner F, Gerstenbrand F, Egger G, Mair A, Rungger G y cols. Body iron stores and presence of carotid atherosclerosis: results from the Bruneck Study. Arterioscler Thromb 1994; 14: 1625-30. (Pubitemid 24312223)
83. Barbieri M, Ragno E, Benvenuti E, Zito GA, Corsi A, Ferrucci L, Paolisso G. New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 2001; 44: 1232-7. (Pubitemid 33010499)
84. Díaz-Castro J, Alférez MJ, López-Aliaga I, Nestares T, Granados S, Barrionuevo M, Campos MS. Influence of nutritional iron deficiency anemia on DNA stability and lipid peroxidation in rats. Nutrition 2008; 24: 1167-73.
85. Aslan M, Horoz M, Kocyigit A, Ozgonül S, Celik H, Celik M, Erel O. Lymphocyte DNA damage and oxidative stress in patients with iron deficiency anemia. Mutat Res 2006; 601: 144-149. (Pubitemid 44528601)
86. Isler M, Delibas N, Guclu M, Gultekin F, Sutcu R, Bahceci M, Kosar A. Superoxide dismutase and glutathione peroxidase in erythrocytes of patients with iron deficiency anemia: effects of different treatment modalities. Croat Med J 2002; 43: 16-9. (Pubitemid 34157859)
87. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129: 687-702.
88. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002; 40: 27-33. (Pubitemid 34701373)
89. Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L. Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Curr Med Chem 2009; 16: 113-29.
90. Hua NW, Stoohs RA, Facchini FS. Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians. Br J Nutr 2001; 86: 515-9.
91. Batida S, Vaquero MP, Veldhuizen M, Sánchez-Muniz FJ. Selected trace elements and minerals in cord blood: association with lipis and lipoproteins at bith. Acta Paediatr 2000; 89: 1201-6.
92. Berger HM, Mimby S, Gutteridge JMC. Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: implications for oxidative stress. Free Rad Res 1995; 22: 555-9.
93. Canales A, Sánchez-Muniz FJ. Paraoxonasa ¿Algo más que un enzima? Med Clin (Barc) 2003; 12: 537-48.
94. Nus M, Sánchez-Muniz FJ, Sánchez-Montero JM. Arilesterasa. Aspectos metodológicos y funcionales de una enzima clave en la enfermedad cardiovascular. Parte I. An R Acad Nac Far 2007; 74: 5-27.
95. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004; 114: 104-8. (Pubitemid 38857573)
96. Tussing-Humphreys LM, Liang H, Nemeth E, Freels S, Braunschweig CA. Excess adiposity, inflammation, and irondeficiency in female adolescents. J Am Diet Assoc 2009; 109: 297-302.
97. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22: 1145-58. (Pubitemid 28548534)
98. Sharma AM. Adipose tissue: a mediator of cardiovascular risk. Int J Obes Relat Metab Disord 2002; 26 (Suppl. 4): S5-7.
99. Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT, Yanovski JA. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 2007; 31: 1412-9. (Pubitemid 47339930)
100. Kaltwasser JP, Werner, Schalk K, Hansen C, Gottschalk R, Seidlc C. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut 1998; 43: 699-704. (Pubitemid 28520107)
101. Samman S, Sandström B, Toft MB, Bukhave K, Jensen M, Sørensen SS, Hansen M. Green tea or rosemary extract added to foods reduces nonheme-iron absorption. Am J Clin Nutr 2001; 73: 607-12. (Pubitemid 32176513)
102. Kim EY, Ham SK, Shigenaga MK, Han O. Bioactive dietary polyphenolic compounds reduce nonheme iron transport across human intestinal cell monolayers. J Nutr 2008; 138: 1647-51.
103. Hernández-Figueroa T, Rodríguez-Rodríguez E, Sánchez-Muniz FJ. El té verde ¿una buena elección para la prevención de enfermedades cardiovasculares? ALAN 2004; 54: 380-94.
104. Butt MS, Sultan MT. Green tea: nature's defense against malignancies. Crit Rev Food Sci Nutr 2009; 49: 463-73.
105. Schneider C, Segre T. Green tea: potential health benefits. Am Fam Physician 2009; 79: 591-4.
106. Navas-Carretero S, Pérez-Granados AM, Sarriá B, Carbajal A, Pedrosa MM, Roe MA, Fairweather-Tait SJ, Vaquero MP. Oily fish increases iron bioavailability of a phytate rich meal in young iron deficient women. J Am Coll Nutr 2008; 27: 96-101. (Pubitemid 351600528)
107. Navas-Carretero S, Pérez-Granados AM, Schoppen S, Sarriá B, Carbajal A, Vaquero MP. Iron status biomarkers in iron deficient women consuming an oily fish versus a red meat diet. J Physiol Biochem 2009; 65 (2).
108. Navas-Carretero S, Pérez-Granados AM, Schoppen S, Vaquero MP. An oily fish diet increases insulin sensitivity compared to a red meat diet in young iron-deficient women". Br J Nutr 2009; 19: 7.
109. Navas-Carretero S, Pérez-Granados AM, Sarriá B, Vaquero MP. Iron absorption from meat pate fortified with ferric pyrophos-phate in iron-deficient women. Nutrition 2009; 25: 20-4.
110. Navas-Carretero S, Pérez-Granados AM, Sarriá B, Vaquero MP. A comparative study of iron bioavailability from cacao supplemented with ferric pyrophosphate or ferric fumarate in rats. Ann Nutr Metab 2007; 51: 204-7. (Pubitemid 47290381)
111. Kundu S, Trent III JT, Hargrove MS. Plants, humans and hemoglobins. Trends Plant Sci 2003; 8: 387-93. (Pubitemid 37065225)
112. Proulx AK, Reddy MB. Iron Bioavailability of Hemoglobin from Soy Root Nodules using Caco-2 cell culture model. J Agric Food Chem 2006; 54: 1518-22.
113. Young MF, Glahn RP, Ariza-Nieto M, Inglis J, Olbina G, Westerman M, O'Brien KO. Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. Am J Clin Nutr 2009; 89: 533-8.
114. a edición revisada y ampliada. 2009 (295 pp) (ISBN: 978-84-368-2273-1).
115. Institute of Medicine. Iron. En: Food and Nutrition Board Institute of Medicine, ed. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academy Press, pp. 290-393, Washington, 2001.
116. Swinkels DW, Janssen MC, Bergmans J, Marx JJ. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem 2006; 52: 950-68. (Pubitemid 43794403)
117. Aronow WS, Ahn C. Three-year follow-up shows no association of serum ferritin levels with incidence of new coronary events in 577 persons aged > or = 62 years. Am J Cardiol 1996; 78: 678-9. (Pubitemid 126658625)
118. Moore M, Folsom AR, Barnes RW, Eckfeldt JH. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1995; 141: 719-23.